LANINI, Simone
 Distribuzione geografica
Continente #
AS - Asia 545
EU - Europa 243
NA - Nord America 236
SA - Sud America 119
AF - Africa 11
OC - Oceania 2
Totale 1.156
Nazione #
SG - Singapore 403
US - Stati Uniti d'America 225
BR - Brasile 110
RU - Federazione Russa 99
KR - Corea 79
IT - Italia 54
CN - Cina 24
DE - Germania 23
NL - Olanda 12
FR - Francia 11
AT - Austria 9
GB - Regno Unito 9
IE - Irlanda 7
MX - Messico 7
AR - Argentina 4
BD - Bangladesh 4
FI - Finlandia 4
PK - Pakistan 4
VN - Vietnam 4
AE - Emirati Arabi Uniti 3
HK - Hong Kong 3
LV - Lettonia 3
TR - Turchia 3
BE - Belgio 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
IN - India 2
LA - Repubblica Popolare Democratica del Laos 2
SE - Svezia 2
ZA - Sudafrica 2
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
BW - Botswana 1
CA - Canada 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ES - Italia 1
ET - Etiopia 1
ID - Indonesia 1
IQ - Iraq 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
PY - Paraguay 1
TG - Togo 1
TN - Tunisia 1
TW - Taiwan 1
UA - Ucraina 1
VE - Venezuela 1
Totale 1.156
Città #
Singapore 358
Boardman 83
Seoul 79
Santa Clara 22
Guangzhou 9
Ashburn 8
Los Angeles 8
Dublin 7
São Paulo 7
Wuhan 7
Düsseldorf 6
Frankfurt am Main 6
Lauterbourg 6
Vienna 6
Nuremberg 5
Shenzhen 5
Udine 5
Belluno 4
Bologna 4
Dong Ket 4
Milan 4
Feira de Santana 3
Islamabad 3
Lappeenranta 3
Mexico City 3
Riga 3
Amsterdam 2
Athens 2
Brussels 2
Buenos Aires 2
Camden 2
Castelraimondo 2
Dhaka 2
Dubai 2
Fayetteville 2
Goiânia 2
Hong Kong 2
Johannesburg 2
Lancenigo-Villorba 2
London 2
Natal 2
Newark 2
Padova 2
Palermo 2
Porto Alegre 2
Portsmouth 2
Ribeirão das Neves 2
Stockholm 2
Tallinn 2
Tbilisi 2
Tel Aviv 2
Vientiane 2
Adamantina 1
Addis Ababa 1
Afonso Cláudio 1
Alpinópolis 1
Ankara 1
Anápolis 1
Aracati 1
Auckland 1
Baghdad 1
Banī Suwayf 1
Barras 1
Barretos 1
Beijing 1
Belford Roxo 1
Belo Horizonte 1
Bento Gonçalves 1
Betim 1
Bishkek 1
Blumenau 1
Bogotá 1
Boston 1
Bragança 1
Brasília 1
Brooklyn 1
Cabo Frio 1
Cametá 1
Campodipietra 1
Campos dos Goytacazes 1
Canary Wharf 1
Caracas 1
Caruaru 1
Cascavel 1
Catalão 1
Caxias 1
Caxias do Sul 1
Charlotte 1
Chicago 1
Chisinau 1
Cianorte 1
Ciudad Nezahualcoyotl 1
Ciudad del Este 1
Colatina 1
Colombo 1
Columbus 1
Contagem 1
Coroados 1
Courtfield 1
Cruzeiro 1
Totale 758
Nome #
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia 40
Renal Function and Its Impact on the Concentration of Ceftazidime-Avibactam: A cross-sectional study 31
The middle east respiratory syndrome coronavirus – a continuing risk to global health security 30
Appropriateness of surgical antimicrobial prophylaxis in the Latium Region of Italy, 2008: A multicenter study 28
Case definition for Ebola and Marburg haemorrhagic fevers: a complex challenge for epidemiologists and clinicians 27
Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation 27
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital: USE OF ANTIVIRALS FOR MONKEYPOX IN AN ITALIAN HOSPITAL 26
Safety and effcacy of subcutaneous administration of Beta-Lactams: a Systematic Review and Meta-analysis. (In: The 20th European Doctoral Conference in Nursing Science – EDCNS) 26
Safety and Pharmacokinetic Profiles of Subcutaneous Administration of Beta-Lactams: A Systematic Review 25
Benefits of steroid therapy in COVID-19 patients with different PaO2/FiO2 ratio at admission 25
Criteria for discharge of patients with Ebola virus diseases in high-income countries 24
Noninvasive positive-pressure ventilation 24
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 23
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 23
Analysis of Diagnostic Findings from the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015 22
Risk of infection in patients with lymphoma receiving rituximab: Systematic review and meta-analysis 22
Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects 22
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis 21
Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant 20
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 20
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH 20
Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries 19
Cefepime-Taniborbactam in Complicated Urinary Tract Infection 19
Author's reply: measles on a cruise ship--links with the outbreak in the Philippines 19
Is hepatitis C virus eradication around the corner only 25 years after its discovery? 19
Temporal intra-host variability of mpox virus genomes in multiple body tissues 19
Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient 18
Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: A nationwide surveillance study 18
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in PLWH 18
A large epidemic of hepatitis B in Serbia: An integrated model for outbreak investigations in healthcare settings 18
A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017 18
The surveillance of chikungunya virus in a temperate climate: Challenges and possible solutions from the experience of Lazio Region, Italy 17
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? 17
Viral hemorrhagic fevers: Advancing the level of treatment 17
Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: Outbreak investigation and infection outcome 17
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study 16
Liver transplant recipients and prioritization of anti-HCV therapy: An Italian cohort analysis 16
Epidemiology of HEV in the mediterranean basin: 10-year prevalence in Italy 16
Inflammatory and humoral immune response during ebola virus infection in survivor and fatal cases occurred in sierra leone during the 2014–2016 outbreak in west Africa 16
Reply to Reisler et al 16
Infections in patients taking Rituximab for hematologic malignancies: Two-year cohort study 16
Non-randomised Ebola trials-lessons for optimal outbreak research 16
COVID-19 disease - Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study 16
Detection of recombinant breakpoint in the genome of human enterovirus E11 strain associated with a fatal nosocomial outbreak 15
Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study 15
Risk management of febrile respiratory illness in emergency departments 15
Epidemiology of viral hepatitis in men who have sex with men in Mediterranean Europe: a region-wide sero-surveillance in Rome (Italy) 14
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results 14
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) 14
Local transmission of chikungunya in Rome and the lazio region, Italy 14
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count 14
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV 14
Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study 14
Ebola virus disease complicated with viral interstitial pneumonia: A case report 13
Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C? 13
Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser 13
Relationship between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study 13
Hiv/hcv co-infection: Putting the pieces of the puzzle together 13
Hospital cluster of HBV infection: Molecular evidence of patient-to-patient transmission through lancing device 13
Hepatitis C: global epidemiology and strategies for control 13
Short-term economic impact of the Zika virus outbreak 13
RE: Measles on the cruise ship: Links with virus spreading into an emergency department in southern Italy 13
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study) 13
Authors reply: measles on the cruise ship: links with virus spreading into an emergency department in Southern Italy 13
Blood kinetics of Ebola virus in survivors and nonsurvivors 13
High-level tolerance to triclosan may play a role in Pseudomonas aeruginosa antibiotic resistance in immunocompromised hosts: Evidence from outbreak investigation 12
Hepatitis C virus treatment revolution: Need for close monitoring 12
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19 12
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron waves 12
Measles cases during ebola outbreak, West Africa, 2013–2106 12
Incidence of SARS-CoV-2 Infection and Related Mortality by Education Level during Three Phases of the 2020 Pandemic: A Population-Based Cohort Study in Rome 12
The added value of long-lasting preparedness for the management of a patient with Ebola 12
Recovery of metabolic impairment in patients who cleared chronic hepatitis C infection after direct-acting antiviral therapy 12
SELP Asp603Asn and severe thrombosis in COVID-19 males 12
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV 12
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection 12
Frequency of detection of upper respiratory tract viruses in patients tested for pandemic H1N1/09 viral infection 12
The possible effect of sociobehavioral factors and public health actions on the mpox epidemic slowdown 12
Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach 12
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox 12
Pulmonary involvement during the Ebola virus disease 12
Influenza A (H1N1) in Rome, Italy in family: Three case reports 12
Ebola: Missed opportunities for Europe-Africa research 11
SARS-CoV-2 Early Screening at the Point of Entry: Travelers From Bangladesh to Italy–July 2020 11
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study 11
Patient to patient transmission of hepatitis B virus: A systematic review of reports on outbreaks between 1992 and 2007 11
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents 11
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19 9
Totale 1.474
Categoria #
all - tutte 8.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 6 0 0 0 0 0 4
2021/20224 0 0 0 0 0 0 0 0 0 1 2 1
2022/20232 1 0 0 0 0 1 0 0 0 0 0 0
2023/20247 0 0 0 0 1 0 0 3 0 1 0 2
2024/20251.451 1 464 206 30 45 66 61 64 111 67 336 0
Totale 1.474